clinicaladvisor.com

Diabetes insulin type does not affect myocardial infarction risk

HealthDay News — For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, ...
Kaleido Scope

N-terminal Pro-B-type Natriuretic Peptide and Microsize Myocardial Infarction Risk in the REGARDS Study

N-terminal pro B-type peptide (NT-proBNP) has been associated with risk of myocardial infarction (MI), but less is known about the relationship between NT-proBNP and very small non ST-elevation MI, ...
Medical Dialogues

Beta Blockers Cut Cardiovascular Events by 25 percent in Post-MI Patients with Mildly Reduced LVEF: Meta-Analysis

Long-term oral β-blocker therapy, including bisoprolol, metoprolol, and carvedilol, reduces the composite endpoint of all-cause death, new myocardial infarction, or heart failure by 25% in ...
The New England Journal of Medicine

Evolocumab in Patients without a Previous Myocardial Infarction or Stroke

The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...
Becker's Hospital Review

Study: Type of General Anesthesia May Not Affect Risk of Myocardial Infarction

A report published in Circulation found the choice of general anesthetic may not affect the risk of myocardial infarction in patients undergoing non-cardiac surgery, according to News-Medical. A ...
The New England Journal of Medicine

Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction

The benefit of complete revascularization in older patients (≥75 years of age) with myocardial infarction and multivessel disease remains unclear. A total of 1445 patients underwent randomization (720 ...